BAYER A.G. (BAYZF)
Clinical trial NCT06904274 updates: 1. completion date: 2027-10-01 → 2027-11-01 2. primary completion date: 2027-10-01 → 2027-11-01
Clinical trial NCT06904274 updates: 1. completion date: 2027-10-01 → 2027-11-01 2. primary completion date: 2027-10-01 → 2027-11-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical